UBS Highlights 30 Stocks Poised for Potential Moves After the Fed's Expected Rate Cut
Express News | Bio Rad Laboratories Inc : RBC Raises Target Price to $446 From $401
Bio-rad Laboratories Insider Sold Shares Worth $989,815, According to a Recent SEC Filing
Wall Street Today | Monday Market Climbs, But Not Past Last Weeks Fall
Moovin Stonks | Market on the Rise, Meme Stocks Climbing
Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?
Palantir, Dell, Nvidia, Apple, Boeing, Oracle, and More Stock Market Movers
The "AI giant stock" Palantir and Dell will join the s&p 500 index! Effective before the market opened on September 23rd.
Their inclusion reflects the demand for artificial intelligence reshaping the financial market; American Airlines, Etsy, and Bio-Rad Laboratories will exit the index.
Palantir, Dell Stocks Jump on S&P 500 Addition
Palantir, Dell to Join S&P 500
Palantir Technologies, Dell Technologies, And S&P MidCap 400 Constituent Erie Indemnity Co. Set To Join S&P 500; Will Replace American Airlines Group, Etsy And Bio-Rad Laboratories
We Think Bio-Rad Laboratories (NYSE:BIO) Can Stay On Top Of Its Debt
Nephron Initiates Bio-Rad Laboratories(BIO.US) With Buy Rating, Announces Target Price $390
Jefferies Maintains Bio-Rad Laboratories(BIO.US) With Hold Rating, Raises Target Price to $340
Wells Fargo Initiates Coverage On Bio-Rad Laboratories With Equal-Weight Rating, Announces Price Target of $340
Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference
Express News | Bio Rad Laboratories Shares Down 1.1%; Co Appoints Jon Divincenzo President, COO
Bio-Rad Laboratories Names Jon DiVincenzo COO
Express News | Bio-Rad Appoints Jon Divincenzo President, Chief Operating Officer
RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Maintains Target Price $401